Big data. Small data. De-identified data. Anonymized data.
data points feed your patient engagement and site selection processes. The challenge
is finding meaningful metrics that drive
actionable insights and optimal trial outcomes.
PPD owns the most robust form of patient data: fully identified information on 100 million households of opted-in patients who are instantly accessible for trial recruitment, patient feedback and patient reported outcomes.
Fully identified patient data distinguishes PPD as a leader in data-driven feasibility, patient recruitment and retention
PPD triangulates data from a variety of sources to:
- Assess study feasibility
- Assess standard of care
- Optimize protocol and trial
- Identify optimal sites
- Recruit qualified patients
PPD Patient Data are Fully Identified
WHERE PATIENTS ARE (Geographically)
Anonymized data from medical claims, pharmacy and other large datasets
Where Patients Are (Disease-State)
Anonymized electronic medical record (EMR) data with only disease-specific information, patients not identified
WHO PATIENTS ARE (LOCATION, demographics, disease-state)
FULLY IDENTIFIED DATA
Proprietary database of 100 million households of opted in patients with self-reported diseases and clinical trial histories
Site and Patient Visualization tool
PPD’s proprietary Site and Patient Visualization tool combines fully-identified patient data with site and study data to pinpoint the optimal mix of countries and sites for your study and your patient population.
- Fully automated cloud tool aggregates, integrates and geocodes data
- Predictive analytics compare study scenarios and optimize site selection
Data-driven feasibility triangulates data from site, patient and landscape sources
We combine our proprietary patient data with external sources to provide the most comprehensive view of patient, site, industry and investigator data to optimize patient enrollment and site selection.
Site & Investigator Data
- Site/account profile
- Feasibility survey responses
- Internal trial performance
- External trial performance
- Prescribing behavior
- Publications/thought leadership
- Site grant/payment benchmarks
- Site visits
- KOL surveys
- Physician notes
- Consumer data
- Standard of care
- Treatment pathways/paradigms
- Competitive trials
- Competitive pipelines
- Regulatory data
- Political, economic, social data
To learn about our enrollment and site activation offerings.